Process Characterisation & Design Space
Understanding how a process behaves — which parameters matter, how they interact, what changes with scale, where the operating range sits, and what control strategy holds the product inside its specification. Without that understanding an organisation can prove three batches worked and cannot explain why the fourth did not. Characterisation is what converts validation from a demonstration into an argument.
What an explainer is not
A topic explainer is SPEQ’s synthesis of what a practice involves, cited to the standards that govern it. It does not reproduce their text, and it does not determine which of them apply to your product or process.
[ POSITION IN THE FRAMEWORK ]
7 DIMENSIONS · 22 LINKSCharacterisation buys the right to move: a design space is only worth having if it was mapped by deliberately going to its edges, and a range established by never leaving the centre is a set point with wider labelling.
06 · QUALITY MATURITY — PROCESS CHARACTERISATION & DESIGN SPACE, REACTIVE TO ADAPTIVE
The process is what the laboratory did, scaled up. Parameters have set points and nobody knows what happens either side of them.
Ranges are documented and a risk assessment names critical parameters, but the ranges came from what was run rather than from what was explored.
Critical parameters are identified from their effect on quality attributes and studied across their ranges, including at the edges, at a scale that is defensible.
Scale-dependence is understood so the knowledge survives transfer, and the control strategy states which parameters are controlled and which are monitored.
The process is understood well enough that a deviation is diagnosable from first principles and a change can be justified without a new campaign.
SPEQ’s shared five-stage progression, labelled synthesis — not the FDA QMM rating scale. Where does your organization sit? Score your quality system →
07 · REGULATORY & EVIDENCE
GOVERNING STANDARDS · 5
Derived from the 5 standards SPEQ maps to this subject, across 3 regulatory bodies: FDA, EMA, ICH.
RECORDS & OBJECTIVE EVIDENCE
- The risk assessment linking process parameters to quality attributes
- Characterisation studies across parameter ranges, including edge-of-range work
- Scale-down model qualification, where characterisation was done at small scale
- The design space or proven acceptable ranges, with the data establishing them
- The control strategy stating what is controlled, monitored and tested
COMMON INSPECTION FINDINGS
- Ranges claimed as studied that were only ever run near their centre
- A scale-down model used for characterisation with no qualification against full scale
- Critical parameters identified by consensus rather than by demonstrated effect
- A design space claimed in the filing that the underlying data does not span
- Deviations investigated empirically because the process was never characterised
Criticality is established, not assumed
ICH Q11 describes development of the manufacturing process for drug substances and ICH Q8 the equivalent for drug product, and both rest on the same move: linking process parameters to product attributes through experimentation rather than through assumption. A parameter is critical because varying it changes a critical quality attribute, and that is a finding, not a designation.
The common shortcut is to designate everything critical, which feels conservative and is not. It produces a control strategy in which every parameter has a tight range, deviations are frequent and mostly meaningless, and genuine excursions are indistinguishable from noise. Establishing what is genuinely critical is what makes the remaining controls credible.
Design space and the ranges that are actually studied
A design space is the multidimensional combination of input variables and process parameters demonstrated to provide assurance of quality. Movement within it is not a change; movement out of it is. That is a substantial regulatory benefit and it is earned by studying interactions, not by widening single-parameter ranges.
The point most often missed is that a design space claimed across a range that was never studied at the edges is not a design space. Univariate experiments at nominal conditions cannot support a multivariate claim, and a regulator reading the submission will look for exactly that gap. It is more defensible to claim a narrow, well-supported region than a wide one resting on extrapolation.
Scale is where process understanding is tested
Processes behave differently at scale, and the differences are not always intuitive: mixing time, heat transfer, shear, hold times, surface-to-volume ratio. A parameter that was not critical at laboratory scale can become the controlling one at commercial scale, and a scale-down model used to justify commercial ranges has to be shown to be representative rather than merely smaller.
This is where development and manufacturing most often disconnect. A process transferred with a parameter list and without the understanding behind it leaves the receiving site unable to judge which deviations matter — so every excursion becomes an investigation, and the site learns the process empirically over its first two years of commercial supply.
SPEQ interpretation — characterisation pays back in the deviation queue
Process characterisation is justified in development terms — filing flexibility, design space, regulatory benefit. Its largest practical return arrives somewhere else entirely: in the ability to disposition an out-of-range result quickly and correctly, because the organisation knows what that parameter does.
A site with genuine process understanding closes a deviation in days with a scientific rationale. A site without it runs a lengthy investigation that concludes there was no product impact, on evidence that amounts to the batch having passed testing. The second is more expensive every single time, and the difference traces directly to work done or not done during development.
FREQUENTLY ASKED
What makes a process parameter critical?
Evidence that varying it changes a critical quality attribute. Criticality is a finding from experimentation, not a designation applied for caution. Designating everything critical produces frequent meaningless deviations and makes genuine excursions indistinguishable from noise.
What is a design space and what does it buy?
The multidimensional combination of input variables and process parameters demonstrated to provide assurance of quality. Movement within it is not a regulatory change; movement out of it is. That flexibility is earned by studying interactions at the edges — a range claimed from univariate experiments at nominal conditions will not support it.
Why does scale-up so often surprise?
Because mixing time, heat transfer, shear, hold times and surface-to-volume ratio all change, and a parameter that was not critical at laboratory scale can become the controlling one at commercial scale. A scale-down model used to justify commercial ranges must be shown to be representative, not merely smaller.
What does process characterisation actually pay back?
Deviation handling. A site with real process understanding dispositions an out-of-range result in days with a scientific rationale; a site without it runs a long investigation concluding no product impact on the evidence that the batch passed testing. The second costs more every time, and the difference was determined during development.